Skip to main content
. Author manuscript; available in PMC: 2010 Jul 15.
Published in final edited form as: Int J Gynecol Cancer. 1994 Jul;4(4):225–240. doi: 10.1046/j.1525-1438.1994.04040225.x

Table 3.

Frequency of sexual dysfunctions and across time for patients treated for in situ vulvar disease, and comparison with healthy counterparts*

Patients with in situ vulvar disease
Dysfunction Healthy
counterparts
Before
treatment
1 year
post-
treatment
Follow-up
Inhibited
   desire
21% 13% 23% 15%
Inhibited
   excitement
12% 15% 31% 36%
Inhibited
   orgasm
10% 18% 36% 28%
Dyspareunia 0% 5% 10% 8%
*

Adapted from Andersen et al.(2)

The sample of healthy counterparts were all sexually active at assessment.